Early detection Position LifeHealth as a provider of point-of-care diagnostics that enable rapid disease detection, highlighting immediate value for clinics and labs seeking faster decision-making and improved patient outcomes.

Compact capabilities Leverage the small team size and niche product focus to propose personalized pilot programs, low-risk trials, and flexible pricing for clinics and mobile testing sites seeking scalable entry points.

Cardio screening Emphasize the novel cardiovascular assays under development to expand cross-selling opportunities with cardiology and primary care practices that require proactive monitoring and early intervention capabilities.

Global reach potential Target mid to small-cap laboratories and urgent care networks that need dependable point-of-care analytics, using the IRMA TruPoint lineage as a differentiator in speed and reliability over traditional send-out tests.

Cost and outcomes Frame the value proposition around reduced care costs and improved patient outcomes through early detection, aligning with payer standardization movements and potential reimbursement discussions.